These results suggest that behind suppressed CD3 T-cell proliferation, proliferation of CD4 and CD8 T-cells is differentially modulated in context of underlying conditions between PAD and SAD patients post-IRT. This evidence concerns the gene CD8A and peripheral arterial disease.